Stemedica Cell Technologies
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6350 Nancy Ridge Dr Ste 106, San Diego, ...Phone Number
(858) 658-0910Website
www.stemedica.comRevenue
$23.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Stemedica Cell Technologies
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing progenitor cell and protein therapeutics for underserved medical conditions. The company utilizes a proprietary platform technology to produce high-quality progenitor cell products in a cGMP licensed facility. Stemedica is actively advancing clinical trials in the United States for critical medical conditions, including ischemic stroke and Alzheimer's disease. With a team of experienced scientists and management, Stemedica aims to address significant healthcare challenges through innovative therapies.Explore more
Stemedica Cell Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stemedica Cell Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Stemedica Cell Technologies recently announced quarterly report
Product Launch: Get notified when Stemedica Cell Technologies launches new products
Stemedica Cell Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Stemedica Cell Technologies
Check if Stemedica Cell Technologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Stemedica Cell Technologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Stemedica Cell Technologies has new funding data
Check out if Stemedica Cell Technologies is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Stemedica Cell Technologies
Compare insights from companies similar to Stemedica Cell Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Stemedica Cell Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stemedica Cell Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stemedica Cell Technologies.
Stemedica Cell Technologies financials insights
Gather financial insights about Stemedica Cell Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$45M
2009
Series B
$22M
2020
Debt
$1M
2021
Debt
$1.1M
Stemedica Cell Technologies Tech Stack
A closer look at the technologies used by Stemedica Cell Technologies
See more technologies
Most Recent Scoops
Project
A mid-level source in logistics has indicated that the organization is in the midst of initiatives related to shipping software. Stemedica Cell Technologies is currently evaluating FedEx Ship Manager. John Romeo currently serves as Supply Chain Specialist.
Software, Logistics / Supply Chain
Project
A mid-level source in logistics has indicated that the organization is in the midst of initiatives related to inventory control & management. Stemedica Cell Technologies is currently evaluating vendors to support these efforts. John Romeo currently serves as Supply Chain Specialist.
Logistics / Supply Chain
Project
A mid-level source in logistics has indicated that the organization is in the midst of initiatives related to supply chain management software. Stemedica Cell Technologies is currently evaluating vendors to support these efforts. John Romeo currently serves as Supply Chain Specialist.
Software, Logistics / Supply Chain
Project
A mid-level source has indicated that product safety will be a part of the largest upcoming organizational initiative.
Product Management, Safety
Project
Quality Assurance, Product Management, Quality Management
Stemedica Cell Technologies News & Media
FDA Allows Phase II-B Clinical Trial to Proceed Using Ischemic-Tolerant Mesenchymal Stem Cells to Treat Patients Suffering from Long-COVID
A Phase 2b, Multi-center, Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of Intravenous Allogenic Bone Marrow-derived Mesenchymal Stem Cells in Subjects with Dyspnea Associated with Post-acute Sequelae of SARS-CoV-2 Infection. (PRWeb October 20, 2022) Read the full story at https://www.prweb.com/releases/2022/10/prweb18969705.htmDARIUS ANDERSON TO JOIN STEMEDICA BOARD OF DIRECTORS
Respected and seasoned business leader, investor and political strategist offers multiple talents to stem cell technologies company SAN DIEGO, March 31, 2022 /PRNewswire/ -- Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego-based biotech company specializing in the manufacture...StemProtein Awarded U.S. Patent for Biodegradable Microneedle Device
SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- StemProtein, LLC (a subsidiary of Stemedica Cell Technologies, Inc.) a leading manufacturer of physiologically balanced growth factors, exosomes, and tissue-restoring proteins received United States Patent No. 10,973,757 entitled "Biodegradable...Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19
SAN DIEGO, Aug. 5, 2021 /PRNewswire/ -- Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announces enrollment of patients for its study entitled "A Phase II, Double-blind, Placebo-controlled...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stemedica Cell Technologies
Sign Up For FreeTo access detailed company insights
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing progenitor cell and protein therapeutics for underserved medical conditions. The company utilizes a proprietary platform technology to produce high-quality progenitor cell products in a cGMP licensed facility. Stemedica is act... Read More
